Bloomberg
Abbott Boosts 2026 Profit Guidance as Sales Across Business Rise
Abbott Laboratories raised its 2026 profit guidance after a stronger-than-expected second quarter driven by improved performance across most of its business lines.
View original source — Bloomberg ↗
Related stories
TASS
BusinessJul 16, 2026 · 1 min
Russia, China capable of increasing their trade turnover to $300 bln per year soon — envoy
TASS
TASS
BusinessJul 16, 2026 · 1 min
Next meeting of OPEC+ monitoring committee scheduled for August 2
TASS

The New York Times
BusinessJul 16, 2026 · 1 min
Strait of Hormuz Tanker Traffic Erodes Further as Oil Prices Rise
The New York Times
TASS
BusinessJul 16, 2026 · 1 min
FACTBOX: What we know about removal of Max and VK apps from Google Play
TASS